abstract |
A process is described wherein, using 17α-(3-hydroxyprapyl)-6β,7β,15β,16β- dimethylene-5β-androstane-3β,5,17β-triol (III) as starting product, there is obtained 3β,5-dihydroxy-6β,7β,15β,16β-dimethylene-5β-17α-pregna-21, 17-carbolactone (I), a useful intermediate in the synthesis of the compound drospirenone, having contraceptive action: (Formula III & I) (III) (I) |